My watch list  


Chemical name Bromo-benzodifuranyl-isopropylamine or
Chemical formula C13H12BrNO2
Molecular mass 294.14 g/mol
Melting point decomposes at 240 °C (hydrochloride)
CAS number -
C(Br)C3=C1C=CO3 (R-isomer)

Bromo-DragonFLY, also known as ABDF, is a psychedelic hallucinogenic drug related to the phenethylamine family. Bromo-DragonFLY is considered an extremely potent hallucinogen, only slightly less potent than LSD with a normal dose in the region of 200μg to 800μg, and it has an extremely long duration of action. It is explicitly illegal only in Sweden[citation needed] and Denmark, although it may be considered a controlled substance analogue under US and Australian drug laws. Bromo-DragonFLY has a stereocenter and R-(-)-bromo-DragonFLY is the more active stereoisomer.



The hallucinogenic effect of bromo-DragonFLY is mediated by its agonist activity at the 5-HT2A serotonin receptor. Bromo-DragonFLY also has a high binding affinity for the 5-HT2B and 5-HT2C serotonin receptors.


Bromo-DragonFLY can sometimes be found on "blotters" (small bits of paper containing the substance) similar to the most commonly found distribution method of LSD, thus making it difficult to identify which substance it is carrying. Two deaths have been associated with the ingestion of bromo-dragonFLY in Sweden and Norway [1].


Bromo-DragonFLY was first synthesized by Matthew A. Parker in the laboratory of David E. Nichols in 1998.

Legal Status


As of December 5, 2007 the drug will be banned by law in Denmark. The substance has been deemed illegal in the category of controlled substances by the Danish health minister Jakob Axel Nielsen, after recommandation by the Danish Health Ministry. As of December 5, 2007 the drug is considered a narcotic in Denmark and hence illegal to posses, import and use. Erowid Bromo-Dragonfly vault

See also


  1. ^
  • 'A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor' by M. A. Parker, D. Marona-Lewicka, V. L. Lucaites, D. L. Nelson, and D. E. Nichols in J. Med. Chem. 41(26): 5148-5149 (1998) DOI: 10.1021/jm9803525
  • 'Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists' by J. J. Chambers, D. M. Kurrasch-Orbaugh, M. A. Parker, and D. E. Nichols in J. Med. Chem. 44(6): 1003-1010 (2001) DOI: 10.1021/jm000491y
  • 'Man i 20-årsåldern dog av drogen Dragonfly', Kajsa Hallberg, Tipsa Expressen, 3 April 2007.
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bromo-DragonFLY". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE